# FDA Inspection 1317894 - Carter BloodCare at Hulen - April 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/e2ba2746-17a9-48c9-a4d7-324ee3dc58ba
Source feed: FDA_Inspections

> FDA Inspection 1317894 for Carter BloodCare at Hulen on April 09, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317894
- Company Name: Carter BloodCare at Hulen
- Inspection Date: 2026-04-09
- Product Type: Biologics
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1187284 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/fc5eaee1-e03d-4382-9a97-a89b5236d9b3)
- [FDA Inspection 1187284 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/4a1cb728-506b-4782-94ab-79f014003366)
- [FDA Inspection 1049593 - 2018-04-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/10f56906-53a4-48ea-a24d-02713edeeb7a)
- [FDA Inspection 985181 - 2016-09-09](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/9f61553a-afe1-49e5-b13f-41a8bb501827)
- [FDA Inspection 881450 - 2014-06-03](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-hulen/47faf1bc-0bc3-400f-b5b8-74342eba0b5b)

Company: https://www.keypedia.com/companies/carter-bloodcare-at-hulen/f1afc583-1b08-49fa-ad4c-a800777a79b5

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
